These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 28410406)

  • 21. Clinical trial: phase 2 study of lubiprostone for irritable bowel syndrome with constipation.
    Johanson JF; Drossman DA; Panas R; Wahle A; Ueno R
    Aliment Pharmacol Ther; 2008 Apr; 27(8):685-96. PubMed ID: 18248656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmaceutical Activation or Genetic Absence of ClC-2 Alters Tight Junctions During Experimental Colitis.
    Jin Y; Pridgen TA; Blikslager AT
    Inflamm Bowel Dis; 2015 Dec; 21(12):2747-57. PubMed ID: 26332307
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A randomized, placebo-controlled trial of lubiprostone for opioid-induced constipation in chronic noncancer pain.
    Jamal MM; Adams AB; Jansen JP; Webster LR
    Am J Gastroenterol; 2015 May; 110(5):725-32. PubMed ID: 25916220
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Association of endotoxaemia & gut permeability with complications of acute pancreatitis: Secondary analysis of data.
    Singh N; Sonika U; Moka P; Sharma B; Sachdev V; Mishra SK; Upadhyay AD; Saraya A
    Indian J Med Res; 2019 Jun; 149(6):763-770. PubMed ID: 31496529
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Aspirin-induced increase in intestinal paracellular permeability does not affect the levels of LPS in venous blood of healthy women.
    Gnauck A; Lentle RG; Kruger MC
    Innate Immun; 2015 Jul; 21(5):537-45. PubMed ID: 25398227
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Lubiprostone increases spontaneous bowel movement frequency and quality of life in patients with chronic idiopathic constipation.
    Fukudo S; Hongo M; Kaneko H; Takano M; Ueno R
    Clin Gastroenterol Hepatol; 2015 Feb; 13(2):294-301.e5. PubMed ID: 25158925
    [TBL] [Abstract][Full Text] [Related]  

  • 27. (13) C mannitol as a novel biomarker for measurement of intestinal permeability.
    Grover M; Camilleri M; Hines J; Burton D; Ryks M; Wadhwa A; Sundt W; Dyer R; Singh RJ
    Neurogastroenterol Motil; 2016 Jul; 28(7):1114-9. PubMed ID: 26914765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Excretion ratio of lactulose and mannitol as intestinal permeability index in healthy Chinese volunteers].
    Liu W; Jiang Z; Shu H; Sun M; Li D
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1999 Oct; 21(5):407-11. PubMed ID: 12567442
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alteration of the Intestinal Environment by Lubiprostone Is Associated with Amelioration of Adenine-Induced CKD.
    Mishima E; Fukuda S; Shima H; Hirayama A; Akiyama Y; Takeuchi Y; Fukuda NN; Suzuki T; Suzuki C; Yuri A; Kikuchi K; Tomioka Y; Ito S; Soga T; Abe T
    J Am Soc Nephrol; 2015 Aug; 26(8):1787-94. PubMed ID: 25525179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early gut mucosal dysfunction in patients with acute pancreatitis.
    Liu H; Li W; Wang X; Li J; Yu W
    Pancreas; 2008 Mar; 36(2):192-6. PubMed ID: 18376312
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lubiprostone--a novel treatment for irritable bowel syndrome with constipation.
    Owen RT
    Drugs Today (Barc); 2008 Sep; 44(9):645-52. PubMed ID: 19137119
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Susceptibility to gut leakiness: a possible mechanism for endotoxaemia in non-alcoholic steatohepatitis.
    Farhadi A; Gundlapalli S; Shaikh M; Frantzides C; Harrell L; Kwasny MM; Keshavarzian A
    Liver Int; 2008 Aug; 28(7):1026-33. PubMed ID: 18397235
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Noninvasive biomarkers of gut barrier function identify two subtypes of patients suffering from diarrhoea predominant-IBS: a case-control study.
    Linsalata M; Riezzo G; D'Attoma B; Clemente C; Orlando A; Russo F
    BMC Gastroenterol; 2018 Nov; 18(1):167. PubMed ID: 30400824
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The obestatin/ghrelin ratio and ghrelin genetics in adult celiac patients before and after a gluten-free diet, in irritable bowel syndrome patients and healthy individuals.
    Russo F; Chimienti G; Linsalata M; Clemente C; Orlando A; Riezzo G
    Eur J Gastroenterol Hepatol; 2017 Feb; 29(2):160-168. PubMed ID: 27750262
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Leaky Gut and the Ingredients That Help Treat It: A Review.
    Aleman RS; Moncada M; Aryana KJ
    Molecules; 2023 Jan; 28(2):. PubMed ID: 36677677
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simultaneous gas-chromatographic urinary measurement of sugar probes to assess intestinal permeability: use of time course analysis to optimize its use to assess regional gut permeability.
    Shaikh M; Rajan K; Forsyth CB; Voigt RM; Keshavarzian A
    Clin Chim Acta; 2015 Mar; 442():24-32. PubMed ID: 25591964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colchicine enhances intestinal permeability in patients with familial Mediterranean fever.
    Fradkin A; Yahav J; Diver-Haber A; Zemer D; Jonas A
    Eur J Clin Pharmacol; 1996; 51(3-4):241-5. PubMed ID: 9010692
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The effect of aspirin and smoking on urinary excretion profiles of lactulose and mannitol in young women: toward a dynamic, aspirin augmented, test of gut mucosal permeability.
    Sequeira IR; Lentle RG; Kruger MC; Hurst RD
    Neurogastroenterol Motil; 2012 Sep; 24(9):e401-11. PubMed ID: 22757650
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gastrointestinal permeability in patients with irritable bowel syndrome assessed using a four probe permeability solution.
    Del Valle-Pinero AY; Van Deventer HE; Fourie NH; Martino AC; Patel NS; Remaley AT; Henderson WA
    Clin Chim Acta; 2013 Mar; 418():97-101. PubMed ID: 23328210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.
    Sequeira IR; Lentle RG; Kruger MC; Hurst RD
    PLoS One; 2015; 10(12):e0143690. PubMed ID: 26629926
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.